Western European Insulin Delivery Devices. Market M62E-52

Transcription

1 Western European Insulin Delivery Devices Market M62E-52

2 Table of Contents Chapter 1 Overview and Executive Summary Overview 1-1 Introduction 1-1 Diabetes 1-1 Insulin Therapy 1-2 Insulin Delivery Devices 1-2 Executive Summary 1-2 Chapter 2 Glossary of Terms and Exchange Rates Glossary and Exchange Rates 2-1 Glossary of Terms 2-1 Exchange Rates 2-2 #M62E Frost & Sullivan April 2011 iii

3 Chapter 3 Total Western European Insulin Delivery Devices Market Analysis Total Western European Insulin Delivery Devices Market 3-1 Market Overview 3-1 Research Scope and Methodology 3-2 Segmentation 3-4 Geographic Segmentation 3-4 Product Segmentation 3-4 Industry Challenges 3-4 Early Diagnosis and Treatment Still A Challenge 3-5 Effective Diabetes Management Still Elusive 3-5 Lack of R&D for treatment of Type I Diabetes 3-6 Market Engineering Measurements 3-6 Revenue Forecasts 3-7 Chapter 4 Insulin Delivery Devices Market Analysis by Market Segment Insulin Syringes 4-1 Introduction to Insulin Syringes 4-1 Market Drivers and Restraints 4-1 Market Drivers 4-2 Product Loyalty Among Elderly Secures Market Base 4-2 Low Cost Advantageous in Price-sensitive Countries 4-2 Hospital Preference of Syringe Use Spurs Market Growth 4-2 Market Restraints 4-3 Fear of Needles a Major Deterrent 4-3 Less Convenience Restricts Usage 4-3 Competition from Rising Popularity of Pens 4-3 Market Engineering Measurements 4-4 Insulin Syringes Revenue Forecasts 4-5 Competitive Structure 4-6 Market Share Analysis 4-7 #M62E Frost & Sullivan April 2011 iv

4 Insulin Pens 4-8 Introduction to Insulin Pens 4-8 Market Drivers and Restraints 4-8 Market Drivers 4-8 Manufacturers Choosing Pens Drives Market 4-9 Preference of Younger Generation Increases Pen Usage 4-9 Suitability to Fast-paced, Modern Lifestyle Drives Market Growth 4-9 Market Restraints 4-9 Resistance to Change Deters Pen Usage 4-9 Extreme Fear of Needles is Still a Restraint 4-10 Market Engineering Measurements 4-10 Insulin Pens Revenue Forecasts 4-11 Competitive Structure 4-12 Market Share Analysis 4-12 Insulin Pumps 4-14 Introduction to Insulin Pumps 4-14 Market Drivers and Restraints 4-15 Market Drivers 4-15 Pump Therapy Aids Effective Management in Difficult Cases 4-15 Elimination of Need for Multiple Injections an Advantage 4-15 Increasing Acceptance due to Advantages and Effectiveness 4-16 Market Restraints 4-16 Reimbursement still an issue affecting growth 4-16 Constant Contact with Device is an Irritant 4-16 Skin Irritation and Site Infections are a Concern 4-16 Market Engineering Measurements 4-17 Insulin Pumps Revenue Forecasts 4-17 Competitive Structure 4-19 Market Share Analysis 4-19 #M62E Frost & Sullivan April 2011 v

5 Needle Free Injection Jets 4-21 Introduction to NFIJ 4-21 Market Drivers and Restraints 4-21 Market Drivers 4-21 Eliminated Risk of Injury and Infection Drives Market 4-22 Absence of Needles Spurs Usage Amongst Belonephobics 4-22 Market Restraints 4-22 Lack of Reimbursement Restricts Usage 4-22 Need for Insulin Iteration a Deterrent 4-22 Insulin Manufacturers Do Not Choose NFIJ 4-23 Market Engineering Measurements 4-23 NFIJ Revenue Forecasts 4-24 Competitive Structure and Market Share Analysis 4-25 Chapter 5 Insulin Delivery Devices Analysis by Geographic Region Insulin Delivery Device Market in the United Kingdom 5-1 Introduction to Healthcare in the United Kingdom 5-1 The Healthcare System in the United Kingdom 5-1 The United Kingdom Revenue Forecasts 5-2 Insulin Delivery Device Market in Germany 5-8 Introduction to Healthcare in Germany 5-8 The Healthcare System in Germany 5-8 Germany Revenue Forecasts 5-8 Insulin Delivery Device Market in France 5-14 Introduction to Healthcare in France 5-14 The Healthcare System in France 5-14 France Revenue Forecasts 5-14 #M62E Frost & Sullivan April 2011 vi

6 Insulin Delivery Device Market in Spain 5-20 Introduction to Healthcare in Spain 5-20 The Healthcare System in Spain 5-20 Spain Revenue Forecasts 5-20 Insulin Delivery Device Market in Italy 5-26 Introduction to Healthcare in Italy 5-26 The Healthcare System in Italy 5-26 Italy Revenue Forecasts 5-27 Insulin Delivery Device Market in Benelux 5-32 Introduction to Healthcare in Benelux 5-32 The Healthcare System in Benelux 5-32 Belgium 5-33 The Netherlands 5-33 Luxembourg 5-33 Benelux Revenue Forecasts 5-33 Insulin Delivery Device Market in Scandinavia 5-38 Introduction to Healthcare in Scandinavia 5-38 The Healthcare System in Scandinavia 5-38 Norway 5-39 Sweden 5-39 Denmark 5-39 Finland 5-39 Scandinavia Revenue Forecasts 5-39 #M62E Frost & Sullivan April 2011 vii

7 Chapter 6 Strategic Recommendations Recommendations for Western European Insulin Delivery Device Market Participants 6-1 Strategic Recommendations 6-1 Collaboration of Insulin and IDD Manufacturers 6-1 Patient GP Raised Awareness 6-1 Online Forums for Product Positioning 6-2 Stress on Research and Development 6-2 Chapter 7 Database of Key Industry Participants Industry Participants 7-1 List of Industry Participants 7-1 Chapter 8 Decision Support Databases Databases Relevant to the Research 8-1 Government Healthcare Expenditure 8-1 Total Healthcare Expenditure 8-3 Diabetes Incidence 8-5 Prevalence of Diabetes 8-8 Prevalence Per cent of Diabetes 8-10 #M62E Frost & Sullivan April 2011 viii

8 List of Figures Chapter 3 Total Western European Insulin Delivery Devices Market Analysis 3-1 Total Insulin Delivery Devices Market: Impact of Top Three Industry Challenges (Western Europe), Total Insulin Delivery Devices Market: Revenue Forecasts (Western Europe), Chapter 4 Insulin Delivery Devices Market Analysis by Market Segment 4-1 Insulin Delivery Devices Market: Market Drivers Ranked in Order of Impact for Insulin Syringes Segment (Western Europe), Insulin Delivery Devices Market: Market Restraints Ranked in Order of Impact for Insulin Syringes Segment (Western Europe), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Western Europe), Insulin Delivery Devices Market: Competitive Structure for Insulin Syringes Segment (Western Europe), Insulin Delivery Devices Market: Company Market Share for Insulin Syringes Segment (Western Europe), #M62E Frost & Sullivan April 2011 ix

9 4-6 Insulin Delivery Devices Market: Market Drivers Ranked in Order of Impact for Insulin Pens Segment (Western Europe), Insulin Delivery Devices Market: Market Restraints Ranked in Order of Impact for Insulin Pens Segment (Western Europe), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Western Europe), Insulin Delivery Devices Market: Competitive Structure for Insulin Pens Segment (Western Europe), Insulin Delivery Devices Market: Company Market Share for Insulin Pens Segment (Western Europe), Insulin Delivery Devices Market: Market Drivers Ranked in Order of Impact for Insulin Pumps Segment (Western Europe), Insulin Delivery Devices Market: Market Restraints Ranked in Order of Impact for Insulin Pumps Segment (Western Europe), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Western Europe), Insulin Delivery Devices Market: Competitive Structure for Insulin Pumps Segment (Western Europe), Insulin Delivery Devices Market: Company Market Share for Insulin Pumps Segment (Western Europe), Insulin Delivery Devices Market: Market Drivers Ranked in Order of Impact for NFIJ Segment (Western Europe), Insulin Delivery Devices Market: Market Restraints Ranked in Order of Impact for NFIJ Segment (Western Europe), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Western Europe), #M62E Frost & Sullivan April 2011 x

10 Chapter 5 Insulin Delivery Devices Analysis by Geographic Region 5-1 Insulin Delivery Devices Market: Revenue Forecasts (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts (Germany), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Germany), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Germany), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Germany), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Germany), Insulin Delivery Devices Market: Revenue Forecasts (France), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (France), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (France), #M62E Frost & Sullivan April 2011 xi

11 5-14 Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (France), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (France), Insulin Delivery Devices Market: Revenue Forecasts (Spain), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Spain), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Spain), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Spain), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Spain), Insulin Delivery Devices Market: Revenue Forecasts (Italy), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Italy), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Italy), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Italy), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Italy), Insulin Delivery Devices Market: Revenue Forecasts (Benelux), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Benelux), #M62E Frost & Sullivan April 2011 xii

12 5-28 Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Benelux), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Benelux), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Benelux), Insulin Delivery Devices Market: Revenue Forecasts (Scandinavia), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Scandinavia), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Scandinavia), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Scandinavia), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Scandinavia), Chapter 8 Decision Support Databases 8-1 Decision Support Database: Government Healthcare Expenditure in Billion USD (World), Decision Support Database: Total Healthcare Expenditure in Billion USD (World), Decision Support Database: New Cases of Diabetes in '000 (World), Decision Support Database: Prevalence of Diabetes in '000 (World), Decision Support Database: Prevalence per cent of Diabetes (World), #M62E Frost & Sullivan April 2011 xiii

13 List of Charts Chapter 3 Total Western European Insulin Delivery Devices Market Analysis 3.1 Total Insulin Delivery Devices Market: Market Engineering Measurements (Western Europe), Total Insulin Delivery Devices Market: Revenue Forecasts (Western Europe), Chapter 4 Insulin Delivery Devices Market Analysis by Market Segment 4.1 Insulin Delivery Devices Market: Market Engineering Measurements for Insulin Syringes Segment (Western Europe), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Western Europe), Insulin Delivery Devices Market: Company Market Share for Insulin Syringes Segment (Western Europe), Insulin Delivery Devices Market: Market Engineering Measurements for Insulin Pens Segment (Western Europe), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Western Europe), Insulin Delivery Devices Market: Company Market Share for Insulin Pens Segment (Western Europe), #M62E Frost & Sullivan April 2011 xiv

14 4.7 Insulin Delivery Devices Market: Market Engineering Measurements for Insulin Pumps Segment (Western Europe), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Western Europe), Insulin Delivery Devices Market: Company Market Share for Insulin Pumps Segment (Western Europe), Insulin Delivery Devices Market: Market Engineering Measurements for NFIJ Segment (Western Europe), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Western Europe), Chapter 5 Insulin Delivery Devices Analysis by Geographic Region 5.1 Insulin Delivery Devices Market: Revenue Forecasts (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (The United Kingdom), Insulin Delivery Devices Market: Revenue Forecasts (Germany), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Germany), #M62E Frost & Sullivan April 2011 xv

15 5.8 Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Germany), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Germany), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Germany), Insulin Delivery Devices Market: Revenue Forecasts (France), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (France), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (France), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (France), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (France), Insulin Delivery Devices Market: Revenue Forecasts (Spain), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Spain), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Spain), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Spain), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Spain), Insulin Delivery Devices Market: Revenue Forecasts (Italy), #M62E Frost & Sullivan April 2011 xvi

16 5.22 Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Italy), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Italy), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Italy), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Italy), Insulin Delivery Devices Market: Revenue Forecasts (Benelux), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Benelux), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Benelux), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Benelux), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Benelux), Insulin Delivery Devices Market: Revenue Forecasts (Scandinavia), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Syringes Segment (Scandinavia), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pens Segment (Scandinavia), Insulin Delivery Devices Market: Revenue Forecasts for Insulin Pumps Segment (Scandinavia), Insulin Delivery Devices Market: Revenue Forecasts for NFIJ Segment (Scandinavia), #M62E Frost & Sullivan April 2011 xvii

17 3 Total Western European Insulin Delivery Devices Market Analysis Total Western European Insulin Delivery Devices Market Market Overview Diabetes is a condition that results in affected individuals experiencing high blood glucose levels when compared to healthy individuals. When untreated, this high concentration of glucose in the bloodstream leads to various complications and finally death. Treatment of diabetes is generally undertaken through change in lifestyle and eating habits during the onset stages. This is followed by the prescription of oral anti-diabetics drugs or insulin. The above-mentioned treatment methods may also be prescribed in combination. The hormone that can lower the level of blood glucose is insulin. Insulin is produced in the beta cells of the pancreas. Insulin is artificially produced and injected subcutaneously to aid in managing the blood glucose levels of diabetics. In the last ten years, total sales of insulin worldwide have risen by an average of xx per cent per annum to roughly $ x billion. The market leader in insulin is Denmark's Novo Nordisk. Novo caters to approximately xx per cent of the entire insulin market. A comprehensive range of medical equipment is required by patients to inject (or have injected) insulin. Diabetes equipment, which consists of blood glucose monitoring supplies and insulin delivery supplies accounted for about x per cent of the total spending on medical devices in Germany this year. The size of this market in Europe is an important and profitable business area for numerous companies. #M62E Frost & Sullivan April

18 Research Scope and Methodology Each Frost & Sullivan research service follows a stringent methodology. Once a title has been identified, it is first subjected to a feasibility check to establish its potential impact and commercial viability. Once the decision has been approved, the lead analyst works in conjunction with the team to analyse the project, based on market issues that have been ascertained through primary research at the feasibility stage. Having established the research service structure, the initial data collection commences. This prepares the analyst team for conducting primary interviews. Contact lists are drawn up and interviews are arranged with known industry and end-user contacts. Internal Frost & Sullivan resources and databases are used to establish market straw models for subsequent validation. Once this has been performed, there is sufficient information to design and validate the questionnaire that forms the basis of the primary interviews. The primary research is then conducted. Interviews are conducted across a broad crosssection of personnel of the following designations: Product managers Marketing managers Marketing directors Sales managers Heads of business development The R&D community Opinion leaders in primary and secondary care, public and private sectors Department heads, clinicians and physicians Trade and industry associations Government officials and implementation agencies #M62E Frost & Sullivan April

19 These interviews, spread across each geographic region, provide cross verification of data and fresh input into revenues, growth rate, equipment replacement rate, unit shipment and installed base, among others. Frost & Sullivan takes a bottom-up approach, looking at market metrics country by country, using interviews at each country level to look at the basic issues and the impact they are likely to have on revenues and growth. These issues include an examination of how the healthcare delivery model differs from country to country, the regulatory framework for healthcare companies, as well as the regulatory barriers to entry and the best route to market for global companies and smaller market participants alike. These factors shape the market calculations, which result in an overall sizing of the market. Once all primary research has been completed, the transcripts can then be examined in line with all secondary research and internal Frost & Sullivan databases. Input from primary research is applied to all market data to establish the market metrics. Sales activity and contracts are closely monitored throughout the year and are employed in conjunction with the average pricing at this stage to establish base year revenue and market share. Wherever possible, revenue is based on invoice payment as opposed to order entry. The forecasting tool is based on the following: Econometric model Quantitative market input Qualitative trends that have an impact on growth rate Weighting model Strategic review committee The reliability of forecast is based on a series of quality checks. These include: Basic approach Cross-validation Several respondents within one company Cross-validating with other market participants Unique relationships with the industry End-user input in all research services Unmet needs Cross-validation #M62E Frost & Sullivan April

20 Once the metrics are established, they are used to illustrate the qualitative lessons learned through secondary research and primary interviews. They form the basis of Frost & Sullivan's in-depth strategic recommendations, as featured in every market engineering research service. Segmentation Geographic Segmentation This research service analyses the insulin delivery devices market in western Europe. The regions included in this analysis are the United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia. Benelux includes Belgium, the Netherlands and Luxembourg and Scandinavia includes Denmark, Sweden, Finland and Norway. Product Segmentation The insulin delivery devices market has been segmented as: Insulin syringes Insulin pens Insulin pumps Needle-free injection jets (NFIJ) Insulin pens have been segmented as reusable pens, disposable pens, and pen needles. By application, these products include all healthcare providers and home users. Industry Challenges Figure 3-1 shows the impact of the top three industry challenges in the total Western European insulin delivery devices market from 2010 to #M62E Frost & Sullivan April

21 Figure 3-1 Total Insulin Delivery Devices Market: Impact of Top Three Industry Challenges (Western Europe), Challenge 1-2 Years 3-4 Years 5-7 Years Early diagnosis and treatment still a challenge Medium Effective diabetes management still elusive High Lack of R & D for treatment of type I diabetes Low Source: Frost & Sullivan Early Diagnosis and Treatment Still A Challenge There are xxx million adults living with diabetes, representing six per cent of the adult population and the numbers are increasing by seven million per year. It is projected that by 2025, there will be nearly xxx million adults with diabetes worldwide. An estimated three million people in the United Kingdom are currently living with diabetes of which, up to xxx,xxx may be undiagnosed. Undiagnosed diabetes is one of the greatest health challenges in Europe. The large population of undiagnosed diabetics represents about xx per cent of the diabetes market. Effective Diabetes Management Still Elusive The management of type-ii diabetes can be brought about with the change in lifestyle and eating habits. Type-II diabetes is typically seen in adult populations over 40. However, studies show that an increasing number of youngsters in the age group of xx-xx are developing type-ii diabetes. The treatment of younger type-ii diabetics with anti-diabetic drugs, as opposed to insulin, is considered a matter of controversy. The administration of insulin in young type-ii diabetics may preserve the long-term health of these individuals. The management of post-parandial blood glucose levels is another area where effective management of diabetes has not been achieved. Limited efficacy, when coupled with undesired side-effects, thereby increases non-compliance to therapy and resultantly, the insulin delivery device market. #M62E Frost & Sullivan April

22 Lack of R&D for treatment of Type I Diabetes Type-I diabetes is characterised by the total inability of the body to produce the hormone insulin. Type-I diabetics are at greater risk of injury due to excursions in blood glucose levels as opposed to type-ii diabetics. Their enhanced need for effective blood glucose management needs to be addressed by increased R&D investment. However, type-i diabetics make up only about xx percent of the world diabetic population and form a niche user group in the larger diabetes market. Market Engineering Measurements Chart 3.1 represents the market engineering measurements for the total western European insulin delivery devices market in Chart 3.1 Total Insulin Delivery Devices Market: Market Engineering Measurements (Western Europe), 2009 Challenge Identification Market Engineering Drives Market Strategy and Planning Market Engineering System Implementation Market Engineer Market Research Market Strategy Market Planning Measurement Name Measurement Trend Market age Growth stage Increasing Revenues Potential revenues (maximum future market size) Base year market growth rate Compound annual growth rate Price sensitivity Degree of technical change $x,xxx.x million $x,xxx.x million x.x% x.x% xxxxxx xxxxxx Note: All figures are rounded; the base year is Source: Frost & Sullivan #M62E Frost & Sullivan April